Cargando…
CD8+ TILS Expression in Invasive Breast Carcinoma (No Special Type)
Invasive breast carcinoma (IBC) is the most cancer in women (24%) and the cause of cancer death in women worldwide. Based on data from globocan 2018 shows the incidence of breast cancer is around 2.08 million (11.6%) which is the second rank of all cancers after lung cancer with a mortality rate of...
Autores principales: | Astuti, Astuti, Miskad, Upik A, Arsyadi, Gunawan, Zainuddin, Andi A, Wahid, Syarifuddin, Nelwan, Berti J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587859/ https://www.ncbi.nlm.nih.gov/pubmed/35633568 http://dx.doi.org/10.31557/APJCP.2022.23.5.1813 |
Ejemplares similares
-
The Relationship Between Expression of EpCAM Cancer Stem Cell Marker with Histopathological Grading, Lymphovascular Invasion, and Metastases in Colorectal Adenocarcinoma
por: Gaghana, Lenda Olivia, et al.
Publicado: (2023) -
CD133 Act as an Essential Marker in Ovarian Carcinogenesis
por: Ikram, Dzul, et al.
Publicado: (2021) -
Progesterone Receptor Expression and Score Differences in Determining Grade and Subtype of Meningioma
por: Poniman, Jeni, et al.
Publicado: (2020) -
Prognostic Value of β-Catenin and L1CAM Expressions in Type I Endometrial Carcinoma
por: Manule, Yolanda, et al.
Publicado: (2023) -
Risk-stratification machine learning model using demographic factors, gynaecological symptoms and β-catenin for endometrial hyperplasia and carcinoma: a cross-sectional study
por: Masadah, Rina, et al.
Publicado: (2023)